Biophytis (EPA:ALBPS)

PRESS RELEASE

published on 04/29/2024 at 14:39, 1 year 11 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces the implementation of a dedicated partnership strategy in obesity, aiming to collaborate with global pharmaceutical companies for drug development and commercialization. CEO Stanislas Veillet emphasizes the importance of addressing the obesity medical challenge through partnerships

Biophytis Drug Development Obesity Partnership Strategy Pharmaceutical Companies
BRIEF

published on 04/29/2024 at 07:05, 1 year 11 months ago

Biophytis Advances Partnership Strategy in Obesity Sector

Biophytis Obesity Treatment Healthcare Innovation Pharmaceutical Partnerships BIO101
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 1 year 11 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 1 year 11 months ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 11 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 11 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 1 year 11 months ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 1 year 11 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt (ADR) program, with effective date expected to be April 23, 2024

Biophytis Stock Market American Depositary Receipt ADR Program Ratio Change
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 1 year 11 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt program, affecting ADS to Shares ratio. No new shares issued, trading price may increase. Details provided in the press release

Biophytis Shares Ads American Depositary Receipt Ratio Change
BRIEF

published on 04/18/2024 at 07:05, 1 year 11 months ago

Biophytis Announces New Scientific Advisory Board for Phase 2 Obesity Study

Biophytis Scientific Advisory Board BIO101 Obesity OBA Clinical Study

Published on 04/10/2026 at 19:20, 1 hour 19 minutes ago

Lithium South Announces Closing of the Sale of Its Hombre Muerto North Lithium Project
Published on 04/10/2026 at 17:55, 2 hours 44 minutes ago

Nepra Foods Inc. Reports Preliminary Unaudited Fiscal 2026 Fourth Quarter Revenue of $1.85 Million, Demonstrating Continued Growth Momentum
Published on 04/10/2026 at 17:00, 3 hours 39 minutes ago

Arcus Appoints New Director and Officers
Published on 04/10/2026 at 14:45, 5 hours 54 minutes ago

Secure Blockchain Completes Acquisition of Agentic Solutions Limited, Launches Enterprise Agentic AI Platform
Published on 04/10/2026 at 14:30, 6 hours 9 minutes ago

Wi2Wi Corporation Announces Full Year 2025 Financial Results

View all ACCESSWIRE

Published on 04/10/2026 at 19:00, 1 hour 39 minutes ago

EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/10/2026 at 18:30, 2 hours 8 minutes ago

AGM 2026 - Bossard Holding AG Press Release
Published on 04/10/2026 at 18:20, 2 hours 19 minutes ago

Felicitysolar's Residential LiFePO4 Battery FLB48314TG1-H Wins 2026 Red Dot Design Award
Published on 04/10/2026 at 18:00, 2 hours 39 minutes ago

Partners Group provides interim business update
Published on 04/10/2026 at 17:30, 3 hours 9 minutes ago

Swiss Re shareholders approve all proposals at AGM 2026

View all EQS

Published on 04/10/2026 at 18:35, 2 hours 3 minutes ago

Disclosure of trading own shares
Published on 04/10/2026 at 18:26, 2 hours 13 minutes ago

EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
Published on 04/10/2026 at 18:00, 2 hours 39 minutes ago

Declaration of voting rights at the end of March 2026
Published on 04/10/2026 at 17:45, 2 hours 54 minutes ago

Imerys-10-04-2026-implementation of the share buyback program
Published on 04/10/2026 at 10:00, 10 hours 39 minutes ago

Recticel Group’s acoustic materials used in NASA’s Artemis II-mission

View all LES ECHOS COMFI WIRE

News